Physician profile
Nicholas Beaulieu
NPI 1679680557
$335.98
in general payments reported to CMS, 2019-2025
10 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.77 · 2020: $59.38 · 2022: $56.46 · 2023: $167 · 2024: $20.63 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $111.55 | 2023 | |
| Pfizer INC. | $41.46 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $36.88 | 2019-2020 | |
| Glaxosmithkline, LLC. | $28.36 | 2022 | |
| Hologic Sales and Service, LLC | $28.10 | 2022 | |
| Genentech USA, INC. | $21.74 | 2020 | |
| Valneva USA, INC. | $20.63 | 2024 | |
| Bavarian Nordic A/S | $20.00 | 2025 | Vivotif |
| Medline Industries LP | $13.73 | 2023 | |
| Viiv Healthcare Company | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Beaulieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.